Academician Wu Yiling: There are 330 million cardiovascular patients in China, and the common pathogenesis is microvascular lesions.

On October 24, 2020, the 16th International Conference on Road Diseases and the 8th Congress of Chinese and Western Medicine combined with Vascular Disease were held in Shijiazhuang Ering Health City.
Liu Depei, Yang Baofeng, Ding Jian, Zhang Yun, Chen Zhinan, Liu Changxiao, Ge Junbo, Wang Rui, Zhang Yingze, Liu Liang, Yu Xiaolin, Wang Junzhi, Wu Yiling and more than 10 academicians from both houses, as well as domestic authoritative Chinese and Western medical experts gathered to conduct in-depth academic exchanges on the unique value of disease theory guiding the prevention and treatment of a variety of incurable diseases. At the
meeting, Academician Wu Yiling made an academic report entitled "The Construction of Chinese Medicine's Pulse Theory and Its Guidance for the Prevention and Control of Microvascular Lesions", and introduced the major achievements made in theory, mechanism and clinical aspects of the project "The Construction of Chinese Medicine's Pulse Theory and Its Guidance of Microvascular Lesions Prevention and Control", which won the first prize of national scientific and technological progress.
the first prize of the National Science and Technology Progress Award for "Constructing the Theology of Chinese Medicine and Guiding the Prevention and Control of Microvascular Lesions".
Wu Yiling pointed out in the report that cardiovascular disease, diabetes and other major diseases seriously endanger human health and life.
data show that the number of cardiovascular diseases in China is 330 million, 2 out of every 5 deaths are cardiovascular diseases, china has 129.8 million diabetics, diabetic nephropathy prevalence rate of 30% to 50%.
Wu Yiling academician said that microvascular is the most important organ to determine human health, not only bear the transport function of blood, is the most important link to the blood to the organs of the tissues, but also the main place of material exchange between blood and tissue organs, the structure and function of microvascular normal to maintain the function of the heart, brain, kidneys and other organs play an important role.
The construction of Chinese medicine vein therapy and its guidance of microvascular lesions prevention and control" project research results show that microvascular lesions are a common mechanism for the development of cardiovascular and kidney diseases, the protection of microvascular endoblast cells is the core mechanism for the treatment of microvascular lesions, is the prevention and treatment of cardiovascular diseases and diabetes and other major diseases breakthrough.
The American Journal of Microcirculation also suggests that the essence of cardiovascular disease is microcirculation disorder, which is the main cause and aggravating factor of cardiovascular disease.
Wu Yiling academician stressed in the report, in the view of Chinese medicine, all over the body's vein system is mainly responsible for running blood, the smallest part of the vein is highly consistent with western medicine's microvascular, so the concept of "Sun-microvascular" has become the Chinese and Western medicine research microvascular lesions theory binding point and treatment breakthrough.
The vasculation theory constructed by Wu Yiling academician system to guide the prevention and treatment of microvascular lesions is a major theoretical original achievement, while the communication Chinese medicine heart capsule developed under the guidance of the vein theory has been confirmed by a large number of basic research and clinical evidence-based medical research, with the function of protecting microvascular vessels.
The drug can protect endodermic cells, inhibit their apoptosis, promote their proliferation, make vascular endothelectrine cells closely connected, thereby improving endothormic barrier function, and can extend the survival time of microvascular vessels in istemia isoemic environment, protect the morphological integrity of microvascular, and promote the rebirth of microvascular vessels in infarction areas, realize the protection of isovascular tissue, and protect microvascular endoblast cells as the key mechanism for treating microvascular disease.
, the National 973 Program Project Acceptance Expert Group agreed that the project "has made a major breakthrough in the treatment of microvascular lesions in Chinese medicine."
At the same time, Academician Wu Yiling pointed out that the research project "Constructing and guiding the prevention and treatment of microvascular lesions in Chinese medicine" has carried out a large number of clinical trials using internationally recognized methods of evidence-based medical research to solve the major problems in the international medical community - the heart capsule solves the medical problems of the world of acute heart infarction; Cardiac capsules provide a new drug for the treatment of heart insulation with room-based early beat, filling the gap of drug treatment with slow and slow early-beating and integrated rhythm of sinus cardiac arrest, and the strong heart capsule ofsignificantly improves the clinical treatment effect of chronic heart failure.
, the three drugs have been included in drug guidelines, expert consensus or academic materials.
National 973 Program Project Acceptance Expert Group said: This study "created the 'theory, clinical, new drugs, experiments and evidence-based' integration of chinese medicine academic innovation and transformation of the new model, traditional Chinese medicine theory innovation and modern science and technology combined to produce significant original results, for the Chinese medicine heritage and innovation and development made a model." In the
report, Academician Wu Yiling also introduced the first prize of national scientific and technological progress, "the construction of Chinese medicine vein thesis and its guidance of microvascular lesions prevention and control" scientific and technological achievements landing transformation project, is currently focusing on building by the physical hospitals, network hospitals, experts, intelligent wearables, drugs, health care products, such as the pulse of cardiovascular health ecosystem, which caused widespread concern and high evaluation of participants.
MedSci Original Source: MedSci Original Copyright Notice: All text, images and audio and video materials on this website that state "Source: Mets Medicine" or "Source: MedSci Originals" are owned by Mets Medicine and are not authorized to be reproduced by any media, website or individual, and are authorized to be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here.